SHENZHEN, China, March 28, 2026 /PRNewswire/ — MicroCloud Hologram Inc. (Nasdaq: HOLO) (“MicroCloud” or the “Company”) today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2025, with the U.S. Securities and Exchange Commission (the “SEC”). MicroCloud is dedicated to the research, development, and application of holographic technology, striving to offer leading holographic technology services to customers.

The Company delivered strong operating and financial performance in 2025, highlighted by robust revenue growth, continued net loss improvement and a substantial strengthening of liquidity and capital resources.

Financial Highlights for Fiscal 2025:

Total revenue reached RMB 403.7 million (USD 56.5 million), representing a 39.1% increase from RMB 290.3 million in 2024, driven by strong demand for holographic solutions and expanded holographic technology services.

Net loss continued to narrow to RMB 50.2 million (USD 7.0 million), compared with a net loss of RMB 64.2 million in 2024, demonstrating steady operational efficiency improvement.

Customer quality and retention improved. And overall customer retention rate rose to 41% in 2025 from 34% in 2024.

Working capital was approximately RMB 2,693.7 million (USD 383.2 million) as of December 31, 2025, representing a 70.5% increase from RMB 1,580.2 million in 2024, ensuring ample financial flexibility for long-term growth.

The information disclosed in this press release does not purport to be complete and is qualified in its entirety by reference to the Company’s annual report on Form 20-F. The annual report, which contains the Company’s audited consolidate statements, can be accessed on the SEC’s website at http://www.sec.gov and on the Company’s investor relations website at http://ir.mcholo.com/..

The Company will provide a copy of its annual report containing the audited consolidated financial statements, free of charge, to its shareholders upon request. Requests should be directed to Investor Relations Department, Room 302, Building A, Zhong Ke Na Neng Building,Yue Xing Sixth Road, Nanshan District, Shenzhen,The People’s Republic of China..

About MicroCloud Hologram Inc.

MicroCloud provides a wide range of holographic technology services in the holographic industry, including high-precision holographic light detection and ranging (LiDAR) solutions based on holographic technology, exclusive holographic LiDAR point – cloud algorithm architecture design, breakthrough holographic imaging technology solutions, holographic LiDAR sensor chip design, and holographic vehicle intelligent vision technology to serve customers that provide reliable holographic advanced driver assistance systems (ADAS). MicroCloud also offers holographic digital twin technology services for customers and has established a proprietary holographic digital twin technology resource library.

Safe Harbor / Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements can be identified by terms such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” and similar expressions. Statements that are not historical facts, including statements about the Company’s beliefs and expectations, are forward-looking statements. Among other things, the business outlook and the Company’s strategic and operational plans contain forward-looking statements. Forward-looking statements are not guarantees or assurances of future performance and involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: the Company’s goals and strategies; the Company’s future business development, financial condition, and results of operations; the expected growth of the holographic industry; and the Company’s expectations regarding demand for and market acceptance of its products and services. Further information regarding these and other risks is included in the Company’s annual report on Form 20-F, and current report on Form 6-K, as well as other documents filed with the SEC. All information provided in this press release is as of the date of this press release, and the Company does not assume any obligation to update any forward-looking statement, except as required under applicable laws.

XIAMEN, China, March 28, 2026 /PRNewswire/ — Hitek Global Inc. (NASDAQ: HKIT) (“Hitek Global” or the “Company”),a China-based information technology consulting and solutions service provider, today announced that it has entered into securities purchase agreements with certain institutional investors for the purchase and sale of 100,000,000 Shares of Class A Ordinary Shares (the “Shares”) (or pre-funded warrants in lieu thereof), at an offering price of $0.03 per share in a registered direct offering (the “Offering”).

The gross proceeds to the Company from the registered direct offering are estimated to be approximately $3 million before deducting the placement agent’s fees and other estimated offering expenses. The offering is expected to close on or about March 30, 2026, subject to the satisfaction of customary closing conditions.

Univest Securities, LLC is acting as the sole placement agent.

The registered direct offering is being made pursuant to a shelf registration statement on Form F-3 (File No. 333-279459) previously filed by the Company with the U.S. Securities and Exchange Commission (“SEC”) and became effective by on May 29, 2024. A final prospectus supplement and accompanying prospectus describing the terms of the proposed offering will be filed with the SEC and will be available on the SEC’s website located at http://www.sec.gov. Electronic copies of the final prospectus supplement and the accompanying prospectus may be obtained, when available, by contacting Univest Securities, LLC at info@univest.us, or by calling +1 (212) 343-8888.

This press release does not constitute an offer to sell or the solicitation of an offer to buy, nor will there be any sales of such securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction. Copies of the prospectus supplement relating to the registered direct offering, together with the accompanying base prospectus will be filed by the Company and, upon filing, can be obtained at the SEC’s website at www.sec.gov.

About Hitek Global Inc.

Hitek Global Inc., headquartered in Xiamen, China, is an IT consulting and solutions service provider focusing on delivering services to business in various industry sectors in China. As of the date of this annual report, we have two lines of businesses— 1) services to small and medium businesses (“SMEs”), which consists of Anti-Counterfeiting Tax Control System (“ACTCS”) tax devices, ACTCS services, and 2) services to large businesses, which consists of hardware sales and software sales. We expect to actively develop our system integration services and online service platform in the near future. Our vision is to become a one-stop consulting destination for holistic IT and other business consulting services in China. For more information, visit the Company’s website at http://ir.xmhitek.com/.

Forward-Looking Statements

Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on current expectations and projections about future events and financial trends that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can identify these forward-looking statements by words or phrases such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to” or other similar expressions. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and in its other filings with the U.S. Securities and Exchange Commission.

HONG KONG, March 27, 2026 /PRNewswire/ — 

Introduction

A new shift is taking shape in crypto trading. By embedding AI-driven research and validation tools into exchange-level infrastructure, platforms such as OneBullEx are beginning to define a new kind of technical architecture for the crypto derivatives era. It signals a broader transition in how crypto platforms are built, where intelligence, execution, and system-level efficiency are becoming as important as market access itself.

 Blockchain originally promised ownership, but in crypto futures, that promise was diluted. Participants may have access to markets, yet they often lack visibility into how strategies are validated, how performance is measured, and how execution pipelines operate. That gap between market access and operational transparency is one of the deeper tensions driving the evolution of exchange infrastructure today.

AI reshapes crypto futures infrastructure

Unlike stocks, cryptocurrency markets never close. Bots operate continuously, scanning decentralized finance (DeFi) protocols, social media and news to act within seconds. Coincub estimates that 70% of global trading volume is now executed by algorithms, primarily institutional bots. The quality of data feeding these systems matters as much as speed. Nasdaq’s AI‑driven M‑ELO order type, which uses reinforcement learning to adjust a hidden order’s hold period in real time, increased fill rates by 20.3% and reduced price mark‑outs by 11.4% compared with static parameters.

 The growth of AI-driven trading infrastructure is also changing the architecture of crypto exchanges themselves. Rather than positioning itself broadly, OneBullEx is focusing on a narrower category as a futures-first platform where AI underpins the technical architecture from the ground up. Futures remain the core strategic priority, and the exchange provides a unified environment for quantitative research, strategy validation, and deployment.

 The OneBullEx ecosystem combines three layers of functionality within a single platform. The exchange infrastructure provides the settlement and execution foundation. 300 SPARTANS operates as a systematic execution layer where rules-based programs, each having passed walk-forward testing before deployment, run continuously according to predefined parameters. OneALPHA functions as a quantitative research pipeline that converts natural-language strategy hypotheses into structured, backtested code through a five-agent workflow.

“The structural challenge in crypto futures infrastructure has always been that quantitative research tools and accessible interfaces pull in opposite directions,” said a OneBullEx representative. “We built OneALPHA and 300 SPARTANS into the exchange architecture so that the research-to-deployment pipeline lives in one environment. That integration is what defines the platform’s technical approach.”

Generational adoption and behavioural shifts

A report based on data from the MEXC exchange found that 67% of Gen Z traders activated at least one AI‑powered trading bot in Q2 2025. Younger traders treat bots as volatility management tools: 73% enable bots during market uncertainty and disable them in calmer periods. The report noted that rule-based execution reduced panic-driven exits by 47% compared with manual approaches, as predefined parameters removed the emotional variable from the process.

Yet AI trading is not a panacea. Coincub warns that most profits still accrue to institutional players with capital and co‑location privileges, and bots cannot rescue an inherently bad strategy.

Manual vs algorithmic execution: a structural comparison

The operational gap between manual and automated trading is widening across several dimensions. In terms of speed and latency, manual traders execute through user interfaces with latency measured in seconds or minutes, while algorithmic systems operate in microseconds via co‑located servers. Emotional discipline is another divide: human traders are subject to fear and greed, with panic sell‑offs common, whereas bots execute pre‑defined rules and reduce panic selling by 47%. Availability compounds the problem further, since traders need sleep but crypto markets never close, and bots operate around the clock without interruption. On accessibility, manual trading apps remain widely available with a low barrier to entry, but AI‑driven tools still often require coding knowledge or access to bot platforms, and retail bots face higher fees and slower infrastructure that limit profitability.

One unresolved tension in this space is that many algorithmic tools remain institutionally shaped even when marketed to individual users. OneBullEx’s architectural response is to collapse the gap between research capability and interface usability. OneALPHA makes strategy research accessible through natural language input, while the platform’s integrated validation pipeline (walk-forward optimization, forensic performance breakdowns, glass-box code visibility) provides the kind of rigour typically associated with institutional-grade research workflows.

Risks, regulatory responses and hidden challenges

Even as AI improves efficiency, it introduces new risks. The 2010 Flash Crash showed how algorithmic feedback loops can destabilise markets. Wharton researchers warn that AI trading agents could collude without explicit coordination: algorithms might punish competitors who undercut prices or adopt similar learning biases, leading to higher prices and reduced market liquidity.

Regulators are responding. The U.S. Commodity Futures Trading Commission (CFTC) issued a request for comment in January 2024 asking how AI impedes anti‑fraud enforcement and whether current rules adequately address algorithmic manipulation. Commissioner Kristin Johnson proposed surveys of AI use and heightened penalties for AI‑driven misconduct. The CFTC’s Technology Advisory Committee recommended transparency around black‑box algorithms and adoption of AI risk‑management frameworks aligned with the U.S. National Institute of Standards and Technology (NIST) guidelines.

If AI-native markets are to scale responsibly, automation needs to be supported by transparency, integrity, and auditable performance. OneBullEx reflects that direction through an architecture built around validated research pipelines, fair NAV-based accounting, visible performance histories, and a glass-box approach to strategy code generation that contrasts with the opaque models drawing increasing regulatory scrutiny.

Conclusion

The structural evolution of crypto futures is happening at the infrastructure level. As algorithmic participation grows and regulators push for greater transparency, the architecture of exchanges matters more than it used to. OneBullEx’s approach, embedding quantitative research tools and systematic execution pipelines directly into the exchange, offers one model for how that architecture can evolve.

About OneBullEx

OneBullEx is a next-generation derivatives trading platform offering USDT-settled perpetual futures, automated trading systems, and secure infrastructure for global users. Powered by OneMore Group, OneBullEx combines institutional-grade oversight with cutting-edge trading technology to provide a stable, transparent, and efficient environment for traders worldwide.

PALM BEACH GARDENS, Fla., March 27, 2026 /PRNewswire/ — Better by MTA, the premier global platform connecting medical travelers with trusted facilitators and accredited healthcare providers, proudly announces the addition of distinguished new Platinum Members. These leaders in international hospital care, ophthalmology, aesthetic surgery, and healthcare facilitation further elevate the platform’s commitment to quality, innovation, and seamless patient experiences worldwide.

The newest Platinum Members include:

King Faisal Specialist Hospital & Research Centre (KFSH)

At King Faisal Specialist Hospital & Research Centre (KFSH), international patients from around the world are welcomed with compassionate, personalized, and innovative medical care. Through its International Healthcare Services, the hospital is dedicated to guiding patients through every step of their healthcare journey—ensuring comfort, clarity, and confidence from the first inquiry through full recovery.

The mission of KFSH is to deliver exceptional, personalized healthcare to international patients by connecting them with world-renowned specialists and advanced facilities while ensuring a seamless, comfortable, and stress-free experience. Its vision is to be the preferred global destination for international healthcare, recognized for advanced medical technologies, patient-centered care, and pioneering research.

Supporting this mission is an internationally certified team focused on providing a smooth and supportive experience for patients and their families. Certified Medical Travel Professionals manage the details of the care journey, while medical liaisons and case managers facilitate clear and continuous communication between patients, healthcare providers, and referring physicians. Multilingual support staff provide culturally sensitive assistance in patients’ preferred languages, ensuring clear communication and personalized support throughout the treatment process.

FV Hospital – Vietnam

FV Hospital is a private hospital, wholly foreign-owned, established by a collective of French physicians led by Dr Jean-Marcel Guillon. The hospital formally opened its doors on April 11, 2003. In 2024, FV became a member of Thomson Medical Group – one of South-East Asia’s leading healthcare providers, which has its headquarters in Singapore.

FV was the first hospital in the region to receive HAS certification (Haute Autorité de Santé) from the French National Authority for Health since 2007. It is also the only hospital in Southern Vietnam to have achieved JCI international accreditation four consecutive times, from 2016 to 2025. These prestigious international certifications reflect FV Hospital’s commitment to patient safety and internationally recognized standards of care.

FV currently employs 1,500 staff, including more than 200 doctors from Vietnam, France, Germany, and several other countries. Operating twenty-four hours a day, FV provides a full range of medical services across more than 45 specialties. Over more than two decades, FV has served over six million patient visits, including well over a million international patients from more than 170 countries.

With the ambition of becoming a leading healthcare provider in Asia, FV offers direct billing with over 100 insurance companies and accepts Vietnam’s national health insurance scheme, alongside a range of other financial support options. As a result, patients can access internationally accredited healthcare at approximately 50% of the cost of comparable hospitals in the region.

Dr. Isaac Hindi

American British Cowdray Medical Center (ABC), Santa Fe Campus – Mexico

Dr. Isaac Hindi is a highly respected ophthalmologist specializing in Cornea, Cataract, and Refractive Surgery at the American British Cowdray Medical Center (ABC) – Santa Fe Campus in Mexico City. ABC Medical Center has been recognized by Newsweek as one of the World’s Best Hospitals 2024 and is widely regarded as the most prestigious private hospital in Mexico.

Board-certified by the Mexican Board of Ophthalmology and the International Council of Ophthalmology (ICO), Dr. Hindi has completed advanced international fellowship training in Cornea and Refractive Surgery, with further specialized programs in Israel and Latin America.

ABC Medical Center is Joint Commission International (JCI) accredited and Magnet^® recognized by the American Nurses Credentialing Center (ANCC), distinctions reflecting the highest standards in global healthcare quality, safety, and patient-centered care. For over 14 consecutive years, both ABC campuses have maintained JCI accreditation, underscoring their unwavering commitment to international excellence.

Dr. Hindi offers comprehensive ophthalmology services including advanced cataract surgery, corneal transplantation, glaucoma management and surgery, retinal treatments, ICL surgery, intracorneal ring implantation, and refractive procedures. Services are available in English, Spanish, and Hebrew.

Dr. Patrick Tonnard, MD, PhD

CEO & Founder, Coupure Center for Plastic Surgery & Aesthetic Medical Center 2 (EMC²) – Ghent, Belgium

Dr. Patrick Tonnard is a world-renowned, board-certified plastic and reconstructive surgeon recognized globally as a pioneer in facial rejuvenation. As CEO and Founder of the Coupure Center for Plastic Surgery and EMC² in Belgium, he leads two of Europe’s most respected aesthetic institutions.

Dr. Tonnard is the creator of groundbreaking techniques including the MACS-lift and nanofat grafting, innovations that have transformed global standards for natural, minimally invasive facial rejuvenation. His regenerative approach integrates advanced surgical techniques with stem-cell-based fat grafting methods, delivering results that look natural and endure for 10–15 years.

With more than 100 peer-reviewed scientific publications, over 250 international lectures and live surgical demonstrations, and seven published books, Dr. Tonnard combines clinical mastery with academic leadership. His practice is especially recognized for natural facial rejuvenation and specialized male facial aesthetics, offering patients refined outcomes that restore vitality while preserving individuality.

Emerge Medical Travel

Emerge Medical Travel is a reliable healthcare facilitation platform that links patients from all over the world with AACI-accredited hospitals and well-known Indian medical professionals. Our mission is to create smooth, customized medical journeys that are guided by compassion, safety, and clarity at every stage.

The outstanding patient experience is at the core of our philosophy. Beyond medical care, we make sure each person has a comfortable healing environment, seamless coordination, and substantial support.

Emerge incorporates the Better App, a digital tool that streamlines patient-hospital communication, document sharing, and treatment coordination, in collaboration with the Medical Tourism Association (MTA). This improved system raises the standard of care for patients worldwide, increases transparency, and fosters trust.

Emerge Medical Travel empowers patients to get top-notch healthcare by combining clinical excellence, compassionate service, as well as innovative technologies. The company is driven by a commitment to quality and integrity.

Strengthening the Global Medical Travel Ecosystem

The addition of these Platinum Members reinforces Better by MTA’s mission to build a trusted, technology-driven ecosystem that connects patients with vetted providers and facilitators who meet the highest international standards.

Jonathan Edelheit, CEO of the Medical Tourism Association, stated:

“Better by MTA was created to bring greater transparency, quality, and coordination to the global medical travel industry. Welcoming these new Platinum Members further strengthens our network of world-class providers and facilitators committed to patient safety, innovation, and excellence. These leaders exemplify the level of quality and professionalism that medical travelers deserve.”

As global demand for cross-border healthcare continues to grow, Better by MTA remains at the forefront of advancing trust, technology integration, and patient-centered solutions worldwide.

About Better by MTA

Better by MTA is a global platform that bridges the key players in the medical tourism ecosystem, connecting medical travelers, qualified facilitators, and accredited providers to drive a seamless medical travel process. Better provides access to trusted providers, robust education, financing options, and unparalleled quality care, improving the medical travel experience.

To learn more, visit better.medicaltourism.com.